Group Therapy for Suicidal Thoughts
(ProjectGRRIT Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if a new, shorter group therapy format can reduce suicidal thoughts in active duty service members. It compares Group Brief Cognitive-Behavioral Therapy (G-BCBT), which consists of 12 sessions, to the longer Dialectical Behavior Therapy (DBT) Skills Group program. The trial focuses on enhancing coping skills and overall mental health. Suitable participants include active duty members who have recently experienced suicidal thoughts or made attempts and are seeking treatment in mental health or substance abuse programs. As an unphased trial, this study provides participants the chance to contribute to innovative mental health solutions designed for service members.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your healthcare provider.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your healthcare provider.
What prior data suggests that this group therapy is safe for reducing suicidal thoughts?
Studies have shown promising safety results for both treatments under consideration. Group Brief Cognitive-Behavioral Therapy (G-BCBT) has been tested in various settings and significantly reduces suicide attempts without harmful side effects. One study noted that participants experienced similar reductions in suicidal thoughts as those receiving other therapies, with no increase in negative effects.
Dialectical Behavior Therapy (DBT) is already a well-known treatment. It has proven practical and acceptable to participants. Research indicates it can effectively reduce suicidal thoughts and self-harm behavior. In studies, participants reported fewer self-harming behaviors after treatment.
Both therapies have undergone multiple tests and are generally well-tolerated. Participants in past studies did not report major safety concerns. This suggests these therapies may be safe options for addressing suicidal thoughts in group settings.12345Why are researchers excited about this trial?
Researchers are excited about these therapies because they offer unique approaches to managing suicidal thoughts, particularly among active duty service members. Dialectical Behavior Therapy (DBT) Skills Group is distinct in providing a comprehensive 24-session program focusing on emotional regulation, distress tolerance, and interpersonal effectiveness, which could lead to deeper, long-lasting behavioral changes. On the other hand, Group Brief Cognitive-Behavioral Therapy (G-BCBT) offers a more concise 12-session format, which may appeal to those needing a quicker, targeted intervention. These approaches contrast with standard treatments that typically emphasize individual therapy or medication, offering fresh hope for more effective group-based strategies.
What evidence suggests that this trial's treatments could be effective for reducing suicidal thoughts?
Research has shown that Dialectical Behavior Therapy (DBT), one of the treatments in this trial, reduces suicidal thoughts and attempts. Studies have found that DBT improves management of suicide risk and emotional challenges. Patients using DBT have experienced fewer and less severe suicidal behaviors, making it especially helpful for those with ongoing suicidal thoughts.
Another treatment in this trial is Group Brief Cognitive-Behavioral Therapy (G-BCBT). Although limited information exists on G-BCBT specifically for suicidal thoughts, cognitive-behavioral methods are well-known for improving mental health by changing negative thinking and behaviors. G-BCBT is expected to offer similar benefits to DBT but in a shorter period.26789Who Is on the Research Team?
Robert J Cramer, PhD
Principal Investigator
UNC Charlotte
Are You a Good Fit for This Trial?
This trial is for active duty service members over 18 who are seeking treatment for mental health or substance abuse, can understand English, and consent to participate. They must have had suicidal thoughts with intent or a suicide attempt in the past month. Those with conditions like psychosis that prevent informed consent or outpatient treatment cannot join.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo 12 weekly group therapy sessions of G-BCBT or 24 weekly sessions of DBT
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Dialectical Behavior Therapy (DBT) Skills Group
- Group Brief Cognitive-Behavioral Therapy (G-BCBT)
Dialectical Behavior Therapy (DBT) Skills Group is already approved in United States, European Union, Canada for the following indications:
- Borderline Personality Disorder
- Suicidal Ideation
- Emotional Dysregulation
- Borderline Personality Disorder
- Emotional Dysregulation
- Self-Harm Behaviors
- Borderline Personality Disorder
- Suicidal Ideation
- Mental Health Disorders
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of North Carolina, Charlotte
Lead Sponsor
Ohio State University
Collaborator
United States Naval Medical Center, Portsmouth
Collaborator